Reporting: sourced factual coverage reviewed by the editorial desk.
The Canary Staked INJ ETF began trading on Nasdaq on November 5 under the symbol INJC, according to Injective’s launch notice and Nasdaq’s listing schedule. Canary Capital distributed its launch release on November 6. The fund offers brokerage-account exposure to INJ, the native asset of the Injective blockchain.
The trust holds INJ and seeks to earn more of the asset by participating in network staking. In staking, tokens are committed to help secure a blockchain and validators can earn rewards. Canary says net staking rewards are reflected in the fund’s net asset value. That is different from owning INJ directly and choosing how to stake it: investors hold shares in the trust, and the fund manages the staking program.
Canary’s November 2 preliminary prospectus identifies BitGo Bank & Trust as custodian for the trust’s INJ. The launch release warns that staking rewards can decline and staking can result in a loss of INJ. Canary also says the product is not registered under the Investment Company Act of 1940 and does not carry the same protections as funds registered under that law.
The verified change is a new exchange-listed way to get exposure to INJ and the fund’s staking results. The launch announcement does not establish how much investors put into the fund or what returns they will earn.


Join the conversation
Share your perspective and reply to other readers in Community.
Discuss this article →